HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ProfilePRO, UNIQUE Fragrances Show Personalization Is Not Just For Skin Care

This article was originally published in The Rose Sheet

Executive Summary

The skin-care market has seen the proliferation of offerings touted as addressing individual needs, but the same level of customization should be available in hair care, according to ProfilePRO, newly launched from QVC founder Joseph Segel. Meanwhile, consumers interested in creating their own signature fragrances have another option with the U.S. debut of UNIQUE Fragrances.

You may also be interested in...

Startups Vying To Crack Code For Online Fragrance Sales

In an era of department store closings and mass consumer migration online, fragrance marketers are uniquely disadvantaged by the shrinking opportunity for in-store product testing. A growing field of startups are tackling the challenge via sampling programs, vibrant digital experiences and customization.

FDA’s Cannabidiol Crackdown: What Do Warning Letters Say About CBD In Cosmetics?

Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.

US House Cosmetics Hearing: Preemption, FDA Ingredient Review Could Be Regulatory Reform Snags

Federal preemption of state and local requirements that differ from federal mandates came up repeatedly at the House Energy & Commerce Health Subcommittee’s 4 December cosmetics hearing. Meanwhile, both NGO and industry stakeholders generally support FDA review of cosmetic ingredients, but the details of such a framework likely will be contentious as work progresses.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts